Download PDF
Viszeralchirurgie 2001; 36(3): 119-125
DOI: 10.1055/s-2001-15012
AKTUELLE CHIRURGIE
© Georg Thieme Verlag Stuttgart · New York

Moderne Behandlungskonzepte
beim Analkarzinom

Update treatment concepts in anal carcinomaM.  H.  Seegenschmiedt1 , M.  Betzler2
  • 1Klinik für Radioonkologie, Strahlentherapie und Nuklearmedizin
  • 2Klinik für Allgemeine Chirurgie, Viszeral- und Gefäßchirurgie
  • Alfred Krupp Krankenhaus, Essen
Further Information

Publication History

Publication Date:
31 December 2001 (online)

    Permissions and Reprints

Einführung

Diagnostik und Therapie des Analkarzinoms haben sich in den letzten zwei Jahrzehnten stark gewandelt. Bei der Diagnostik spielen endoluminale Sonographie und Probebiopsie zur genauen Tumorklassifikation eine wichtige Rolle. In der Therapie haben sich funktionelle, den Sphinkter erhaltende Konzepte durchgesetzt, insbesondere die Radiochemotherapie, die sich durch gutes Ansprechen und geringe Nebenwirkungen auszeichnet. Radikale chirurgische Maßnahmen sind heute nur noch unter palliativen Gesichtspunkten und bei Nichtansprechen bzw. Lokalrezidiv nach Primärtherapie erforderlich [6] [7] [13] [19] [26] [30] [31] [36] [39] [43] [46] [51] [55] [57] [59] [61].

Literatur

  • 1 Al Surf A S, Turnbull R B, Fazio V W. Local treatment of squamous cell carcinoma of the anus.  Surg Gynecol Obstet. 1979;  148 576-578
    PubMedGoogle Scholar
  • 2 Allal A S, Kurtz J M, Pipard G. et al . Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison.  Int J Radiat Oncol Biol Phys. 1993;  27 59-66
    PubMedGoogle Scholar
  • 3 Allal A S, Laurencet F M, Reymond M A, Kurtz J M, Marti M C. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment.  Cancer. 1999;  86 405-409
    CrossrefPubMedGoogle Scholar
  • 4 Anthony T, Simmang C, Lee E L, Turnage R H. Perianal mucinous adenocarcinoma.  J Surg Oncol. 1997;  64 218-221
    CrossrefPubMedGoogle Scholar
  • 5 Bartelink H, Roelofsen F, Eschwege F. et al . Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organisation for research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.  J Clin Oncol. 1997;  15 2040-2049
    PubMedGoogle Scholar
  • 6 Basik M, Rodriges Bigas M A, Penetrante R, Petrelli N J. Prognosis and recurrence patterns of anal adenocarcinoma.  Am J Surg. 1995;  169 233-237
    CrossrefPubMedGoogle Scholar
  • 7 Beahrs O H. Management of cancer of the anus.  Am J Roentgenol. 1979;  133 791-795
    PubMedGoogle Scholar
  • 8 Beckman A M, Daling J R, Sherman K J. et al . Human papilloma virus infection and anal cancer.  Int J Cancer. 1989;  43 1042-1049
    PubMedGoogle Scholar
  • 9 Boman B M, Moertel C G, O'Connel M J. et al . Carcinoma of the anal canal - a clinical and pathologic study of 188 cases.  Cancer. 1984;  54 114-125
    CrossrefPubMedGoogle Scholar
  • 10 Cantril S T, Green J P, Schall G L, Schaupp W C. Primary radiation therapy in the treatment of anal carcinoma.  Int J Radiat Oncol Biol Phys. 1983;  9 1271-1278
    PubMedGoogle Scholar
  • 11 Constantinou E C, Daly W, Fung C Y, Willett C G, Kaufman D S, DeLaney T F. Time-Dose considerations in the treatment of anal cancer.  Int J Radiat Oncol Biol Phys. 1997;  39 651-657
    CrossrefPubMedGoogle Scholar
  • 12 Cummings B J, Keane T J, O'Sullivan B, Wong C S, Catton C N. Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-Fluorouracil with and without mitomycin C.  Int J Radiat Oncol Biol Phys. 1991;  21 1115-1125
    CrossrefPubMedGoogle Scholar
  • 13 Cummings B J. Anal cancer.  Int J Radiat Oncol Biol Phys. 1990;  19 1309-1315
    PubMedGoogle Scholar
  • 14 Cutuli B, Fenton J, Labib A, Bataini J P, Mathieu G. Anal margin carcinoma: 21 cases treated at the Institut Curie by exclusive conservative radiotherapy.  Radiother Oncol. 1988;  11 1-6
    CrossrefPubMedGoogle Scholar
  • 15 Daling J R, Weiss N S, Hislop T G. et al . Sexual practices, sexually transmitted diseases, and the incidence of anal cancer.  N Engl J Med. 1987;  317 973-977
    CrossrefPubMedGoogle Scholar
  • 16 Doci R, Zucali R, La Monica G. et al . Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients.  J Clin Oncol. 1996;  14 121-125
    PubMedGoogle Scholar
  • 17 Doggett S W, Green J P, Cantril S T. Efficacy of radiation therapy alone for limited squamous cell carcinoma of the anal canal.  Int J Radiat Oncol Biol Phys. 1988;  15 1069-1072
    PubMedGoogle Scholar
  • 18 Dubois J B, Garrigues J M, Pujol H. Cancer of the anal canal: report on the experience of 61 patients.  Int J Radiat Oncol Biol Phys. 1991;  20 575-580
    PubMedGoogle Scholar
  • 19 Dunst J, Reichard U, Wolf N, Sauer R. Funktionserhaltende Therapie des Analkarzinoms durch simultane Radiochemotherapie.  Dtsch Med Wschr. 1987;  112 1201-1205
    PubMedGoogle Scholar
  • 20 Eschwege F, Laser P, Chavy A. et al . Squamous cell carcinoma of the anal canal: treatment by external beam irradiation.  Radiother Oncol. 1985;  3 145-150
    PubMedGoogle Scholar
  • 21 Flam M S, John M, Pajak T, Petrelli N. et al . Role of mitomycin C in combination with fluorouracil and radiotherapy and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study.  J Clin Oncol. 1996;  14 2527-2539
    PubMedGoogle Scholar
  • 22 Frisch M, Glimelius B, van den Brule A JC. et al . Sexually transmitted infections as a cause of anal cancer.  N Engl J Med. 1997;  337 1350-1358
    CrossrefPubMedGoogle Scholar
  • 23 Frisch M, Olsen J H, Bautz A, Melbye M. Benign anal lesions and the risk of anal cancer.  N Engl J Med. 1994;  331 300-302
    CrossrefPubMedGoogle Scholar
  • 24 Frost D B, Richards P C, Montague E D, Giacco G G, Martin R G. Epidermoid cancer of the anorectum.  Cancer. 1984;  53 1285-1293
    PubMedGoogle Scholar
  • 25 Gerard J P, Ayzac L, Hun D. et al . Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients.  Radiother Oncol. 1998;  46 249-256
    PubMedGoogle Scholar
  • 26 Grabenbauer G G, Matzel K L, Schneider I HF. et al . Sphincter preservation with chemoradiation in anal canal carcinoma - Abdominoperineal resection in selected cases?.  Dis Col Rectum. 1998;  41 441-450
    PubMedGoogle Scholar
  • 27 Grabenbauer G G, Panzer M, Hültenschmidt B. et al . Combined radiation and chemotherapy for squamous cell carcinoma of the anal canal: Results and prognostic variables in a multi-institutional series of 173 patients.  Radiol Oncol. 1997;  31 219-227
    PubMedGoogle Scholar
  • 28 Grabenbauer G G, Panzer M, Hültenschmidt B. et al . Prognostische Faktoren nach simultaner Radiochemotherapie des Analkanalkarzinoms in einer multizentrischen Serie von 139 Patienten.  Strahlenther Onkol. 1994;  170 391-399
    PubMedGoogle Scholar
  • 29 Grabenbauer G G, Schneider I HF, Gall F P, Sauer R. Epidermoid carcinoma of the anal canal: treatment by combined radiation and chemotherapy.  Radiother Oncol. 1993;  27 59-62
    CrossrefPubMedGoogle Scholar
  • 30 Grabenbauer G G, Wolf N, Dunst J, Sauer R. Analkanalkarzinom: Diagnostik-Therapie-Prognose.  Strahlenther Onkol. 1989;  165 829-836
    PubMedGoogle Scholar
  • 31 Hager T, Hermanek P. Maligne Tumoren der analregion. In: Gall FP, Hermanek P, Tonak J (eds) Chirurgische Onkologie.  Berlin; Springer 1987
    Google Scholar
  • 32 Higgins G D, Uzelin D M, Phillips G E. et al . Differing characteristics of human papillomavirus RNA-positive and RNA-negative anal carcinomas.  Cancer. 1991;  68 561-567
    PubMedGoogle Scholar
  • 33 Hill S A, Coghill S B. Human papillomavirus in squamous carcinoma of anus.  Lancet. 1986;  6 1333
    PubMedGoogle Scholar
  • 34 Hoffman R, Welton M L, Klencke B, Weinberg V, Krieg R. The significance of pretretment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer.  Int J Radiat Oncol Biol Phys. 1999;  44 127-131
    CrossrefPubMedGoogle Scholar
  • 35 Holly E A, Whittemore A S, Aston D A. et al . Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking.  J Natl Caner Inst. 1989;  81 1726-1731
    PubMedGoogle Scholar
  • 36 Hughes L L, Rich T A, Delclos L, Ajani J A, Martin R G. Radiotherapy for anal cancer: experience from 1979 - 1987.  Int J Radiat Oncol Biol Phys. 1989;  17 1153-1160
    PubMedGoogle Scholar
  • 37 John M, Flam M, Pajak T. et al . Is mitomycin C necessary in the chemoradiation regimen for anal canal carcinoma? Interim results of a phase III randomized intergroup study.  Int J Radiat Oncol Biol Phys. 1993;  27 191
    PubMedGoogle Scholar
  • 38 John M, Pajak T, Flam M, et al. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.  Cancer J Sci Am. 1996;  2 205-211
    PubMedGoogle Scholar
  • 39 Leichman L, Nigro N, Vaikevicius V K. et al . Cance rof the anal cancer: model for preoperative adjuvant combined modality therapy.  Am J Med. 1985;  78 211-215
    CrossrefPubMedGoogle Scholar
  • 40 Mahjoubi M, Sadek H, Francois E. Epidermoid anal cancer. Activity of cisplatin and continuous 5-FU in metastatic and/or locally recurrent diesease.  Proc Am Soc Clin Oncol. 1990;  9 114
    PubMedGoogle Scholar
  • 41 Martenson J A, Gunderson L L. External radiation therapy without chemotherapy in the management of anal cancer.  Cancer. 1993;  71 1736-1740
    CrossrefPubMedGoogle Scholar
  • 42 Ng Y K, Pigneux J, Auvray H. et al . Our experience of conservative treatment of anal canal carcinoma combining external irradiation and interstitial implant: 32 cases treated between 1973 and 1982.  Int J Radiat Oncol Biol Phys. 1988;  14 253-259
    PubMedGoogle Scholar
  • 43 Nigro N D, Vaitkevicius V K, Considine B. Combined therapy for cancer of the anal canal.  Dis Colon Rectum. 1974;  27 763-766
    PubMedGoogle Scholar
  • 44 Palevsky J M, Holly E A, Hogeboom C J. et al . Anal cytology as a screening tool for anal squamous intraepithelial lesions.  J Aquir Immune Defic Syndr Hum Retroviral. 1997;  14 405-412
    PubMedGoogle Scholar
  • 45 Panzer M, Sutter T, Wendt T, Jauch K W. Radiochemotherapie mit und ohne Radikaloperation bei Analkarzinom: Großhaderner Langzeitergebnisse.  Tumordiagn u Ther. 1993;  14 167-174
    PubMedGoogle Scholar
  • 46 Papillon J, Chassard J L. Respective roles of radiotherapy and surgery in the management of epidermoid carcinoma of the anal margin.  Dis Colon Rectum. 1992;  35 422-429
    PubMedGoogle Scholar
  • 47 Papillon J, Montbaron J F, Gerard J P. et al .Role of combined radiation and chemotherapy; the Lyon experience. In: Sauer R (ed) Interventional radiation therapy.  Springer; Berlin 1991
    Google Scholar
  • 48 Papillon J, Montbaron J F. Epidermoid carcinoma of the anal canal. A series of 276 cases.  Dis Colon Rectum. 1987;  5 324-333
    PubMedGoogle Scholar
  • 49 Peddada A V, Smith D E, Rao A R, Frost D B, Kagan A R. Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal.  Int J Radiat Oncol Biol Phys. 1997;  37 1101-1105
    CrossrefPubMedGoogle Scholar
  • 50 Peiffert D, Seitz J F, Rougier P. et al . Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative study.  Ann Oncol. 1997;  8 575-581
    CrossrefPubMedGoogle Scholar
  • 51 Pintor M P, Northover J M, Nicolls R J. Squamous cell carcinoma of the anus 1948 - 1984.  Br J Surg. 1989;  76 806-810
    CrossrefPubMedGoogle Scholar
  • 52 Pipard G. Combined therapy of anal canal cancer: a report on external irradiation with or without chemotherapy followed by interstitial Ir-192. In: Sauer R (ed) Interventional radiation therapy.  Springer; Berlin 1991
    Google Scholar
  • 53 Pocard M, Tiret E, Nugent K, Dehni N, Pare R. Results of salvage abdominoperineal resection for anal cancer after radiotherapy.  Dis Colon Rectum. 1998;  41 1488-1493
    PubMedGoogle Scholar
  • 54 Roelofsen F, Bosset J, Eschwege F. et al . Concomitant radiotherapy and chemotherapy superior to radiotherapy alone in the treatment of locally advanced anal cancer. Results of a phase III randomized trial.  ASCO Abstr. 1995;  14 194
    PubMedGoogle Scholar
  • 55 Sawyers J L. Squamous cell cancer of the perianus and anus.  Surg Clin N Amer. 1972;  52 935-942
    PubMedGoogle Scholar
  • 56 Schlienger M, Krzisch C, Pene F. et al . Epidermoid carcinoma of the anal canal: treatment results and prognostic variables in a series of 242 cases.  Int J Radiat Oncol Biol Phys. 1989;  17 1141-1151
    PubMedGoogle Scholar
  • 57 Schneider I HF, Grabenbauer G G, Köckerling F, Sauer R, Gall F P. Die Therapie des Analkarzinoms. In: Bünte H, Junginger Th (eds) Jahrbuch der Chirurgie 1993.  Zülpich; Biermann 1993
    Google Scholar
  • 58 Schneider I HF, Grabenbauer G G, Reck T, Köckerling F, Sauer R, Gall F P. Combined radiation and chemotherapy for epidermoid carcinoma of the anal canal.  Int J Colorect Dis. 1992;  7 192-196
    CrossrefPubMedGoogle Scholar
  • 59 Sischy B. The use of radiation therapy combined with chemotherapy in the management of squamous cell carcinoma of the anus.  Int J Radiat Oncol Biol Phys. 1985;  11 1587-1593
    PubMedGoogle Scholar
  • 60 Touboul E, Schlienger M, Buffat L. et al . Epidermoid carcinoma of the anal margin: 17 cases treated with curative intent radiation therapy.  Radiother Oncol. 1995;  34 195-202
    CrossrefPubMedGoogle Scholar
  • 61 Touboul E, Schlienger M, Buffat L. et al . Epidermoid carcinoma of the anal canal.  Cancer. 1994;  73 1569-1579
    PubMedGoogle Scholar
  • 62 UICC .TNM-Klassifikation maligner Tumoren. 5. Aufl. Berlin, Heidelberg, New York; Springer 1997
  • 63 UKCCCR Anal Canal Cancer Working Party . Epidermoid anal cancer: results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin.  Lancet. 1996;  348 1049-1054
    CrossrefPubMedGoogle Scholar
  • 64 Wagner J P, Mahe M A, Romestaing P. et al . Radiation therapy in the conservative treatment of carcinoma of the anal canal.  Int J Radiat Oncol Biol Phys. 1994;  29 17-23
    PubMedGoogle Scholar
  • 65 WHO .Histological typing of intestinal tumors. In: Jass JR, Sobin LH (eds) International Histological Classification of tumors. 2. Aufl.  Heidelberg, New York, Tokyo; Springer 1989: XX
    Google Scholar

Prof. Dr. med. M. Heinrich Seegenschmiedt

Klinik für Radioonkologie,
Strahlentherapie und Nuklearmedizin
Alfried Krupp-Krankenhaus

Alfried-Krupp-Straße 21
45117 Essen

Phone: + 49-201-4342560

Fax: + 49-201-4342371

Email: seegenschmiedt.heinrich@krupp-krankenhaus.de